Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study

PLoS Medicine

Volumn 11, Issue 5, 2014, Pages

  Langenberg, Claudia ^a   Sharp, Stephen J ^a   Franks, Paul W ^b,c   Scott, Robert A ^a   Deloukas, Panos ^d   Forouhi, Nita G ^a   Froguel, Philippe ^e   Groop, Leif C ^f,g   Hansen, Torben ^h,i   Palla, Luigi ^a   Pedersen, Oluf ^h,j,k   Schulze, Matthias B ^l   Tormo, Maria Jose ^m,n,o   Wheeler, Eleanor ^d   Agnoli, Claudia ^p   Arriola, Larraitz ^n,q,r   Barricarte, Aurelio ^n,s   Boeing, Heiner ^l   Clarke, Geraldine M ^t   Clavel Chapelon, Françoise ^u   Duell, Eric J ^v   Fagherazzi, Guy ^u   Kaaks, Rudolf ^w   Kerrison, Nicola D ^a   Key, Timothy J ^x   Khaw, Kay Tee ^a   Kröger, Janine ^l   Lajous, Martin ^u,y,z   Morris, Andrew P ^t   Navarro, Carmen ^m,n,aa   Nilsson, Peter M ^b   Overvad, Kim ^ab,ac   Palli, Domenico ^ad   Panico, Salvatore ^ae   Quirós, J Ramón ^af   Rolandsson, Olov ^c   Sacerdote, Carlotta ^ag,ah,ai   Sánchez, María José ^n,aj   Slimani, Nadia ^ak   Spijkerman, Annemieke M W ^al   Tumino, Rosario ^am,an   van der A, Daphne L ^al   van der Schouw, Yvonne T ^ao   Barroso, Inês ^a,d   McCarthy, Mark I ^t,ap,aq   Riboli, Elio ^e   Wareham, Nicholas J ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF HELSINKI   (Finland)

^h Capital Region   (Denmark)

ⁱ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^j AARHUS UNIVERSITY   (Denmark)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m DEPARTMENT OF EPIDEMIOLOGY   (Spain)

ⁿ INSTITUTO DE SALUD CARLOS III   (Spain)

^o UNIVERSITY OF MURCIA   (Spain)

^p Epidemiology Unit   (Italy)

^q Basque Government   (Spain)

^r BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^s INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^v BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^w GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^x UNIVERSITY OF OXFORD   (United Kingdom)

^y INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^z HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^aa UNIVERSITY OF MURCIA   (Spain)

^ab AARHUS UNIVERSITY   (Denmark)

^ac AALBORG UNIVERSITY HOSPITAL   (Denmark)

^ad CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ae UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^af Cancer Research and Prevention Institute ^*

^ag CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^ah Unit of Cancer Epidemiology   (Italy)

^ai Human Genetics Foundation   (Italy)

^aj ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ak INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^al NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^am Azienda sanitaria provinciale (ASP)   (Italy)

^an Aire Onlus   (Italy)

^ao UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ap UNIVERSITY OF OXFORD   (United Kingdom)

^aq NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; EVALUATION AND FOLLOW UP; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; ALLELE; DIET THERAPY; GENETIC PREDISPOSITION; GENETICS; LIFESTYLE; MOTOR ACTIVITY; PROPORTIONAL HAZARDS MODEL;

ALLELES; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET, MEDITERRANEAN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84901387060     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001647     Document Type: Article

References (45)

1. International Diabetes Federation (2013) IDF diabetes atlas, 6th ed. Brussels: International Diabetes Federation. Available: http://www.idf.org/diabetesatlas/download-book. Accessed 15 April 2014.
2. Neel JV, (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14: 353-362.
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
5. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677-1686.
6. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334: 299.
7. McCarthy MI, (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339-2350.
8. Hivert MF, Jablonski KA, Perreault L, Saxena R, McAteer JB, et al. (2011) Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60: 1340-1348.
9. Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, et al. (2011) Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 54: 2272-2282.
10. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, et al. (2002) Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5(6B): 1147-1162.
11. Spencer EA, Roddam AW, Key TJ, (2004) Accuracy of self-reported waist and hip measurements in 4492 EPIC-Oxford participants. Public Health Nutr 7: 723-727.
12. Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, et al. (2012) Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med 9: e1001230.
13. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5: 1113-1124.
14. The InterAct Consortium (2013) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56: 60-69.
15. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, et al. (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6: 407-413.
16. The InterAct Consortium, (2012) Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol 27: 15-25.
17. Slimani N, Deharveng G, Unwin I, Southgate DA, Vignat J, et al. (2007) The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 61: 1037-1056.
18. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, et al. (1995) Diet and overall survival in elderly people. BMJ 311: 1457-1460.
19. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D, (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348: 2599-2608.
20. Romaguera D, Guevara M, Norat T, Langenberg C, Forouhi NG, et al. (2011) Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care 34: 1913-1918.
21. Buckland G, Agudo A, Lujan L, Jakszyn P, Bueno-de-Mesquita HB, et al. (2010) Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 91: 381-390.
22. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981-990.
23. Kong A, Steinthorsdottir V, Masson G, Thorleifsson G, Sulem P, et al. (2009) Parental origin of sequence variants associated with complex diseases. Nature 462: 868-874.
24. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, et al. (2008) Genes mirror geography within Europe. Nature 456: 98-101.
25. Manica A, Prugnolle F, Balloux F, (2005) Geography is a better determinant of human genetic differentiation than ethnicity. Hum Genet 118: 366-371.
26. The InterAct Consortium (2012) Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia 55: 1944-1952.
27. de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, et al. (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34: 121-125.
28. Buijsse B, Simmons RK, Griffin SJ, Schulze MB, (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33: 46-62.
29. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359: 2220-2232.
30. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359: 2208-2219.
31. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, et al. (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340: b4838.
32. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, et al. (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350: 1838-1849.
33. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, et al. (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355: 467-477.
34. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355: 241-250.
35. Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, et al. (2009) The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. J Clin Endocrinol Metab 94: 449-455.
36. Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, et al. (2008) Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 57: 2503-2510.
37. Orozco G, Ioannidis JP, Morris A, Zeggini E, (2012) Sex-specific differences in effect size estimates at established complex trait loci. Int J Epidemiol 41: 1376-1382.
38. Perry JR, Voight BF, Yengo L, Amin N, Dupuis J, et al. (2012) Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet 8: e1002741.
39. Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson PM, et al. (2009) Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. Diabetes 58: 1411-1418.
40. Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB, (2009) Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr 89: 1453-1458.
41. Sonestedt E, Lyssenko V, Ericson U, Gullberg B, Wirfalt E, et al. (2012) Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort. J Clin Endocrinol Metab 97: E810-E818.
42. Hindy G, Sonestedt E, Ericson U, Jing XJ, Zhou Y, et al. (2012) Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes. Diabetologia 55: 2646-2654.
43. Cornelis MC, Qi L, Kraft P, Hu FB, (2009) TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 89: 1256-1262.
44. Palla L, Higgins JP, Wareham NJ, Sharp SJ, (2010) Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol 171: 1225-1232.
45. Cornelis MC, Tchetgen EJ, Liang L, Qi L, Chatterjee N, et al. (2012) Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes. Am J Epidemiol 175: 191-202.